The bumper is barely scratched, but your neck has not been right since the collision. You are still treating, still in pain, still missing work — and the adjuster keeps circling back to the photos of the car, as if a small dent settles what happened to your spine. That is not an accident of conversation. It is the opening move in a playbook built to make a real injury look like nothing.
Soft-tissue devaluation is the set of tactics Massachusetts insurers use to minimize claims for whiplash, sprains, strains, and other soft-tissue injuries — the ones that do not always show up on an X-ray but can nonetheless be painful and lasting. The strategy leans on a statutory pressure point unique to auto cases: the tort threshold that limits when a crash victim can recover for pain and suffering. Understanding how the devaluation works, and how to defeat it, is what keeps a genuine injury from being written off because the metal held up better than the person did.
This article looks at the tactic from the defense side: the “minor impact, minor injury” script, how objective medical findings answer it, and what crosses the statutory threshold regardless of how the car looks. It is general information, not advice about a specific case, and it builds on our explainer of the Massachusetts tort threshold.
What soft-tissue devaluation is
The tactic is not random skepticism; it is an organized way of exploiting how the law treats these injuries. It is worth understanding as a system, because each piece makes more sense once you see the whole.
The playbook, defined
Soft-tissue devaluation is the deliberate strategy of treating whiplash and similar injuries as inherently exaggerated or non-existent, then building a claim file around that assumption. It shows up as low first offers, demands for “objective proof” that soft-tissue injuries do not always produce, focus on minor vehicle damage, and skepticism about ongoing treatment. None of these is a single dramatic denial; together they form a consistent effort to reframe a painful, disruptive injury as a nuisance not worth paying for. Recognizing it as a coordinated strategy, rather than a fair reaction to a weak claim, is the first step to countering it. The same moves appear claim after claim, which is a strong sign they are a template, not a considered judgment about your particular injury.
Why soft-tissue claims are the target
These injuries are targeted because they are common, genuinely hard to image, and easy to cast as subjective. A torn ligament or an aggravated disc may not appear on a basic film the way a broken bone does, and pain is invisible. That evidentiary softness is what the defense exploits: where the injury cannot be pointed to on a scan, the insurer argues it is not really there, or not really serious. The very features that make these injuries hard to prove are what make them attractive to devalue. An insurer that would never dispute a clean fracture will readily dispute a strained ligament, simply because the ligament does not photograph.
The tort threshold as the lever
What gives the tactic its bite in Massachusetts is the statutory threshold. Under Massachusetts General Laws chapter 231, section 6D, a car-crash victim can recover for pain and suffering only if reasonable and necessary medical expenses cross a statutory figure — unless the injury involves a fracture, permanent and serious disfigurement, substantial loss of sight or hearing, or loss of a body member. Soft-tissue injuries often do not automatically clear that bar, so the whole devaluation strategy aims at a single goal: keep the documented medical expenses and the injury’s severity looking small enough to stay under the threshold and out of pain-and-suffering damages entirely. Understanding that the threshold is the target explains almost every move in the playbook, from the low first offer to the pressure to stop treating.
The minor-impact, minor-injury script
The centerpiece of the tactic is a simple, intuitive-sounding argument that does not hold up as well as it sounds. Its strength is its simplicity; its weakness is that the simplicity is false.
The “minor impact means minor injury” argument
The script, often called a minor-impact soft-tissue argument, runs like this: the vehicle damage was slight, so the forces were slight, so the injury must be slight. Insurers lean on photographs of an undamaged bumper and low repair estimates to suggest the crash could not have hurt anyone much. It is a compelling story for a jury or an unrepresented claimant, because it matches a common intuition — small dent, small harm. That intuitive appeal is exactly why the defense reaches for it first. A story that a jury will nod along to is worth more to the insurer than a technically stronger argument that requires explanation.
Low property damage does not equal low injury
The trouble with the script is that vehicle damage and bodily injury do not track as neatly as it implies. Modern bumpers are designed to absorb and hide low-speed impacts, so a car can look nearly untouched while the occupant’s head and neck were still snapped forward and back. Body size, head position, awareness of the impending hit, and pre-existing vulnerability all affect how a given force translates into injury. A stiff bumper transferring energy to the occupants can, in some cases, produce more injury than a crumpling one. The photo of the car simply does not answer the medical question. What the vehicle looks like and what happened to the person inside it are two different inquiries, and only one of them is medical.
Why the underlying science is contested
The defense often dresses the script in expert language — biomechanical opinions that a given change in velocity could not cause injury. But that field is genuinely contested, the studies are limited and frequently drawn from staged, low-stakes conditions unlike a real crash, and courts do not uniformly accept the conclusions. Presenting the “minor impact” theory as settled science overstates it. Once a claimant understands that the biomechanical certainty is more argument than proof, the script loses much of its authority. It stops being an unassailable scientific verdict and becomes just one more contestable opinion.
How objective findings defeat the script
The devaluation strategy depends on the injury looking subjective, so the counter is to make it objective. Move the injury from the realm of the claimant’s word into the realm of the medical record, and the tactic starts to fail.
Imaging and objective evidence
While a routine X-ray may miss soft-tissue damage, other tools can document it: MRI findings of disc injury or nerve involvement, positive results on physical examination, measured range-of-motion loss, and neurological findings. Where such evidence exists, it converts a “subjective” complaint into a documented condition the insurer cannot wave away. Pursuing the right imaging and examinations when symptoms warrant is one of the most direct answers to the devaluation strategy, because it takes the injury off the page of the claimant’s word and onto the page of the medical record.
Consistent treatment records
Even without dramatic imaging, a consistent, contemporaneous course of treatment is powerful. Regular visits, a documented treatment plan, steady reporting of symptoms, and evidence of functional limitation build a record that is hard to dismiss as invented. Gaps and inconsistencies are what the defense feeds on, so continuity does double duty: it treats the injury and it proves it. A claimant who keeps treating on medical advice and keeps the record complete denies the devaluation the holes it needs.
The treating physician’s opinion
The doctor who actually examined and followed the patient carries real weight against an insurer’s one-time reviewer or a biomechanical theorist who never met them. A treating physician’s opinion on causation, the seriousness of the injury, and its likely permanence answers the defense on the ground where these cases are decided. That firsthand, longitudinal view is difficult to overcome with a records-only critique, which is why the treating relationship is often the most valuable evidence a soft-tissue claim has. A doctor who watched the injury unfold is simply harder to rebut than one who read about it.
What crosses the threshold anyway
The whole devaluation game assumes the claim is stuck under the threshold. Often it is not. Testing that assumption early can collapse the entire strategy in a single stroke.
The fracture and serious-injury exceptions
Section 6D does not require the medical-expense threshold at all when the injury fits certain categories: a fracture, permanent and serious disfigurement, substantial loss of sight or hearing, or loss of a body member. Any of these opens pain-and-suffering damages regardless of the size of the medical bills or how the car looked. A crash the defense wants to call “minor” that in fact produced even a small fracture is not a threshold case at all — it is over the line by the statute’s own terms, and the “minor impact” script becomes irrelevant. Checking early whether any exception applies can end the threshold fight before it starts.
Permanent disfigurement and scarring
Permanent and serious disfigurement is its own path over the threshold, and it reaches injuries the defense might otherwise dismiss — lasting scarring from lacerations or from the surgery an injury required, for example. Because this exception turns on permanence and seriousness rather than a dollar figure, documenting the lasting visible effect of an injury can carry a claim past the threshold even where the medical expenses are modest. It is a route the devaluation strategy tends to ignore, and one worth checking in any case with visible, lasting harm. A scar that will not fade is permanent by definition, and permanence is what the exception asks about.
Meeting the expense threshold itself
Even a pure soft-tissue claim can cross the threshold the ordinary way, by accumulating reasonable and necessary medical expenses above the statutory figure. This is precisely why insurers try to suppress and interrupt treatment: keeping the documented expenses down is how they keep a claim under the line. Consistent, medically appropriate treatment — not padding, but the care the injury genuinely calls for — both helps the patient heal and, where warranted, carries the claim over the threshold on its own. The defense’s interest in a treatment gap is a direct clue to how the threshold math works. If the insurer is quietly hoping you stop treating, it is usually because continued care would push the claim over the line.
How the devaluation shows up in practice
The strategy is not abstract; it arrives through a few recognizable moves an injured person actually encounters.
The biomechanical expert
In litigated cases, the insurer may retain a biomechanical expert to opine that the forces involved were too small to cause the claimed injury. The testimony sounds scientific and authoritative, but it typically rests on generalized studies and staged tests that do not account for the specific claimant — their posture, their vulnerabilities, the exact geometry of the hit. Cross-examination that exposes how little the expert knows about the actual person, and how limited the underlying data are, often deflates the opinion. It is an argument, not a measurement, and it can be answered as one.
The records-review doctor
More common than a biomechanist is the paper-review physician who never examines the claimant but reads the file and pronounces the treatment excessive or unrelated. That report gives the adjuster cover to cut the claim’s value, but it carries a built-in weakness: the reviewer never saw the patient. A treating physician who followed the injury over months, examined the patient repeatedly, and watched the response to treatment speaks from a position the records-only critic cannot match. Framing the contest as firsthand care versus a desk review is often enough to blunt the report. A jury readily understands why the doctor who treated you week after week may know more than one who spent an afternoon with your chart.
The photograph of the car
The simplest and most persistent move is the color photograph of an undamaged bumper, produced at every opportunity as if it settled the medical question. It is powerful precisely because it is intuitive, and it works on claimants and juries who assume damage and injury are proportional. The counter is to keep the focus on the body, not the car: the medical records, the imaging, the treating opinion. A photo of a vehicle is evidence about a vehicle, and letting it stand in for evidence about an injury is the concession the tactic is built to extract. Keeping those two questions separate in your own mind is half the battle.
The soft-tissue myths the defense sells
Underneath the tactics sit a few convenient myths, and naming them takes away their force. Each myth sounds like common sense and dissolves under a closer look.
“All whiplash resolves in a few weeks”
The defense treats soft-tissue injury as uniformly short-lived, but that is not how these injuries actually behave. Many do resolve, but a meaningful share become chronic, producing lasting pain, stiffness, and limitation — and the ones that do not resolve are exactly the serious claims the myth is meant to suppress. Treating every soft-tissue injury as a few weeks of soreness is a generalization the medical reality does not support, and a documented course of persistent symptoms rebuts it directly. Persistence that is charted over months is the answer to a myth that assumes everyone heals on schedule.
“Treatment just means you are building a case”
Insurers imply that ongoing treatment is evidence of a manufactured claim rather than a real injury — a cynical inversion that punishes the very continuity the law rewards. In truth, following a doctor’s treatment plan is what a genuinely injured person does, and stopping care to avoid the appearance of “building a case” only hands the defense a treatment gap. The right course is to treat as the injury requires and let the record reflect medical need, not to shape care around the insurer’s insinuations. Undertreating a real injury to look less litigious is a bad trade for both your health and your claim.
“No emergency room visit means no injury”
Because soft-tissue symptoms are often masked at the scene by adrenaline and emerge over the following days, many injured people do not go to an emergency room immediately — and the defense treats that as proof they were not hurt. The delayed onset of neck and back symptoms is well recognized, and a prompt visit to a physician once symptoms appear is entirely consistent with a real injury. The absence of an ambulance ride proves nothing about the presence of harm, and the medical literature on delayed symptoms answers the argument. Prompt care once the pain sets in is the reasonable response, not evidence that nothing happened.
What this means for your claim
Seen clearly, soft-tissue devaluation is beatable — but only if the claimant refuses to accept the premise that the injury is not real.
Do not accept the “minor” framing
The most important move is to reject the idea that a modest-looking crash cannot cause a serious injury. Vehicle photos do not measure what happened to your body, and a low first offer built on them is a negotiating position, not a medical fact. A whiplash injury can be genuinely disabling even when the car looks fine, and treating your own injury as trivial because the insurer does is exactly the mistake the tactic is designed to produce. The insurer’s low opinion of your injury is a bargaining stance, not a diagnosis, and adopting it as your own only helps the other side.
Build the objective record
Because the strategy exploits the perceived softness of the evidence, the answer is documentation: appropriate imaging when warranted, consistent treatment, a clear record of functional limitation, and a treating physician’s opinion on causation and permanence. That record either carries the claim over the threshold or, where a fracture or disfigurement applies, shows the threshold was never the obstacle. A well-documented soft-tissue injury claim is far harder to devalue than the defense assumes.
The recovery a real injury supports
A soft-tissue injury that meets the threshold, or fits an exception, supports the ordinary categories of recovery — medical costs, lost earnings, and compensation for pain, suffering, and lasting effects — reduced only by any comparative fault. The devaluation strategy is an effort to erase the pain-and-suffering component by keeping the injury under the line. Defeating it is what restores the claim to its actual value rather than the diminished one the insurer prefers. The gap between those two numbers is precisely what the devaluation playbook is built to create.
Deadlines and protecting a soft-tissue claim
The devaluation strategy works best against a claimant who waits, so the clock and the record both reward acting early.
The three-year deadline
A Massachusetts personal-injury claim generally must be filed within three years of the injury under Massachusetts General Laws chapter 260, section 2A. Soft-tissue claims are especially sensitive to timing, because the strength of the medical record depends on treatment that begins promptly and stays consistent. A delayed start to care is itself a devaluation gift, letting the defense argue that a real injury would have been treated sooner. Acting inside the deadline is necessary, but acting early is what actually protects the claim.
Get evaluated and document early
Because these injuries can be masked at first and worsen over days, a prompt medical evaluation matters both for health and for proof. Early documentation ties the symptoms to the crash before the defense can suggest an intervening cause, and it starts the treatment record the threshold analysis depends on. The gap between the crash and the first visit is one of the first things a devaluing insurer looks for, so closing it quickly removes an easy argument and anchors the injury to the event.
When to call a Boston injury lawyer
If an insurer is waving off your soft-tissue injury as minor because the car was barely damaged, that framing is worth challenging rather than accepting, because vehicle photos do not measure your injury and the threshold can be met or bypassed on the medical facts. A lawyer can build the objective record, identify whether a fracture or disfigurement exception applies, and hold the insurer to the actual value of the claim. Our Boston personal injury attorneys handle undervalued crash and soft-tissue injury claims across the Commonwealth; these matters are handled on contingency, so there is no fee unless there is a recovery. If your injury is being treated as nothing because the metal survived, you can reach out to have your options evaluated.
Reviewed and Approved By
This article was reviewed for legal accuracy by Daniel J. Larson, the founding attorney of Larson Law and a Massachusetts-barred personal injury lawyer in Boston. He represents individuals and families harmed by negligence in serious-injury matters arising from motor-vehicle collisions, unsafe property conditions, and other preventable incidents. Attorney Larson takes a litigation-first approach, developing each case through detailed investigation, discovery, and expert analysis with the expectation that it may be tried. Before founding the firm, he defended doctors, hospitals, and other healthcare providers in malpractice litigation at a Boston firm — experience that informs how he anticipates the way insurers and defense counsel evaluate a claim. He is a member of the Massachusetts Bar Association and the Massachusetts Academy of Trial Attorneys.
Frequently asked questions
The other driver’s insurer says my car barely has damage, so my injury must be minor. Is that true?
No. Vehicle damage and bodily injury do not track neatly. Modern bumpers absorb and hide low-speed impacts, so a car can look almost untouched while the occupant’s neck and back were still injured. Factors like head position, body size, and pre-existing vulnerability affect how a force translates into harm. The photo of the car does not answer the medical question, and a “minor impact” argument is a negotiating tactic, not a diagnosis.
My injury does not show up on an X-ray. Can I still recover?
Often, yes. Soft-tissue injuries frequently do not appear on a basic X-ray but can be documented through MRI findings, physical examination, measured range-of-motion loss, and a treating physician’s opinion. Consistent treatment records also carry real weight. The absence of a fracture on a film does not mean the absence of injury, and objective evidence of the kind these injuries do produce answers the “no proof” argument.
What is the tort threshold and why does it matter here?
Massachusetts limits when a car-crash victim can recover for pain and suffering: generally, reasonable medical expenses must cross a statutory figure, unless the injury involves a fracture, permanent and serious disfigurement, substantial loss of sight or hearing, or loss of a body member. Insurers try to keep soft-tissue claims under that line by suppressing treatment and documented expenses, which is why the devaluation tactics and the threshold are so closely linked.
Can a soft-tissue injury ever cross the threshold?
Yes, in more than one way. It can meet the expense threshold through consistent, medically necessary treatment; it can qualify through a fracture that the crash caused; or it can qualify through permanent and serious disfigurement, such as lasting scarring. The defense tends to assume a soft-tissue claim is automatically stuck under the threshold, but the facts often show otherwise.
What is the single best thing I can do to protect the claim?
Get evaluated promptly and treat consistently on your doctor’s advice, so the injury is documented and tied to the crash from the start. The devaluation strategy feeds on delayed care, treatment gaps, and thin records. A prompt, consistent, well-documented course of treatment is the most effective counter, because it converts a supposedly subjective injury into an objective, provable one.
Results Disclaimer: Past case results, settlements, and verdicts mentioned on this website do not guarantee or predict a similar outcome in any future case. Every case is unique and depends on its own facts and legal issues.